Wan-Seob Cho Selected Research

samarium oxide (samarium (III) oxide)

1/2018

High inflammogenic potential of rare earth oxide nanoparticles: the New Hazardous Entity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wan-Seob Cho Research Topics

Disease

13	Inflammation (Inflammations) 01/2022 - 12/2007
11	Pneumonia (Pneumonitis) 01/2022 - 11/2010
4	Neoplasms (Cancer) 11/2010 - 05/2008
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 11/2008
2	Body Weight (Weight, Body) 02/2020 - 09/2008
2	Granuloma 01/2020 - 05/2009
2	Pre-Eclampsia (Preeclampsia) 05/2018 - 02/2018
2	Lung Injury 04/2016 - 09/2011
2	Eosinophilia 01/2016 - 09/2011
2	Fibrosis (Cirrhosis) 12/2012 - 11/2008
1	Neuroinflammatory Diseases 04/2022
1	Alzheimer Disease (Alzheimer's Disease) 03/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Anxiety Disorders (Anxiety Disorder) 01/2022
1	Cytokine Release Syndrome 01/2022
1	COVID-19 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Atherosclerosis 01/2020
1	Pulmonary Alveolar Proteinosis 01/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Rupture 01/2016
1	Pancreatitis 10/2013
1	Adenoma (Adenomas) 09/2008
1	Carcinoma (Carcinomatosis) 09/2008
1	Diarrhea 01/2002
1	Edema (Dropsy) 01/2002

Drug/Important Bio-Agent (IBA)

5	IonsIBA 01/2016 - 04/2012
4	CytokinesIBA 01/2022 - 12/2007
3	indium oxideIBA 01/2020 - 04/2016
3	Immunoglobulin E (IgE)IBA 10/2012 - 05/2009
2	Hormones (Hormone)IBA 01/2022 - 02/2018
2	SuspensionsIBA 02/2020 - 11/2008
2	IndiumIBA 01/2020 - 04/2016
2	Silicon Dioxide (Silica)FDA LinkGeneric 04/2016 - 11/2008
2	nickel monoxide (nickel oxide)IBA 04/2016 - 01/2016
2	OxidesIBA 01/2016 - 04/2012
2	NickelIBA 01/2016 - 12/2012
2	MetalsIBA 01/2016 - 04/2012
2	Zinc Oxide FDA Link 10/2013 - 09/2011
2	alpha-ChlorohydrinIBA 09/2008 - 05/2008
1	eugenitolIBA 04/2022
1	Amyloid (Amyloid Fibrils)IBA 03/2022
1	NanodiamondsIBA 01/2022
1	4,4'-dinitro-2,2'-stilbenedisulfonic acid (DNDS)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 10/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2021
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	LipidsIBA 01/2020
1	Carbon Nanotubes (Carbon Nanotube)IBA 11/2018
1	AsbestosIBA 11/2018
1	Estrogens (Estrogen)FDA Link 05/2018
1	EstersIBA 05/2018
1	Progesterone FDA LinkGeneric 05/2018
1	Proteins (Proteins, Gene)FDA Link 05/2018
1	Estrogen ReceptorsIBA 05/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2018
1	TransferasesIBA 05/2018
1	SteroidsIBA 02/2018
1	samarium oxide (samarium (III) oxide)IBA 01/2018
1	neodymium oxideIBA 01/2018
1	cupric oxide (copper oxide (CuO))IBA 04/2016
1	OvalbuminIBA 01/2016
1	carboxyl radical (COO-)IBA 05/2015
1	cobalt oxideIBA 05/2015
1	CobaltIBA 05/2015
1	Immunoglobulin G (IgG)IBA 10/2012
1	cobalt tetraoxideIBA 10/2012
1	AcidsIBA 04/2012
1	Immunoglobulin A (IgA)IBA 09/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2011
1	glycol-chitosanIBA 11/2010
1	ChitosanIBA 11/2010
1	Contrast MediaIBA 08/2009
1	GoldIBA 04/2009
1	Tissue Inhibitor of Metalloproteinase-1IBA 11/2008
1	Matrix Metalloproteinases (MMPs)IBA 11/2008
1	ChemokinesIBA 12/2007
1	AgarIBA 01/2002

Therapy/Procedure

2	Intravenous Injections 01/2022 - 12/2009
1	Ligation 01/2022
1	Punctures 01/2022
1	Aftercare (After-Treatment) 04/2016
1	Intraperitoneal Injections 10/2012
1	Therapeutics 08/2009